Translational Neurodegeneration Q1
Unclaimed
BioMed Central Ltd
United Kingdom
Translational Neurodegeneration is a journal indexed in SJR in Neurology (clinical) and Cellular and Molecular Neuroscience with an H index of 67. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on neurodegenerative diseases, dementia, motor neurone disease, Parkinson's disease, Alzheimer's disease. It has an SJR impact factor of 3,85 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,85.
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -



Price
2390 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3,85
SJR Impact factor67
H Index66
Total Docs (Last Year)158
Total Docs (3 years)8727
Total Refs1922
Total Cites (3 years)144
Citable Docs (3 years)13.41
Cites/Doc (2 years)132.23
Ref/DocOther journals with similar parameters
Neuro-Oncology Q1
JAMA Neurology Q1
Nature Reviews Neurology Q1
Molecular Neurodegeneration Q1
Brain Q1
Compare this journals
Aims and Scope
Neurodegenerative diseases
Dementia
Motor neurone disease
Parkinson's disease
Alzheimer's disease
Comments